Polypill - the power of one versus many | The George Institute for Global Health

In May 2014, Salim Yusuf, Sydney Smith, Vanessa Selak and Ruth Webster discussed the latest evidence around the use of polypill in the treatment and management of CVD.

Lead:

Dr Ruth Webster

Global Head of Medicine, George Health Technologies

Head Technical Transfer, Genovate

Senior Lecturer, Faculty of Medicine, UNSW Sydney

Related Investigators:

Professor Anthony Rodgers

Professor of Global Health, Faculty of Medicine, UNSW Sydney

Professor Anushka Patel

Vice Principal Director & Chief Scientist, The George Institute for Global Health

Professor of Medicine, UNSW Sydney

Cardiologist, Royal Prince Alfred Hospital

乔治全球健康研究院首席科学家

澳大利亚新南威尔士大学医学教授

阿尔弗雷德王子医院心脏病专家

Related Projects:

Kanyini Guidelines Adherence with the Polypill Study (Kanyini GAP)

Single Pill to Avert Cardiovascular Events (SPACE)

Related Media releases:

Polypill - the power of one versus many

Kanyini Guidelines Adherence with the Polypill Study (Kanyini GAP)

Single Pill to Avert Cardiovascular Events (SPACE)

First international trial shows polypill halves predicted heart and stroke risk - cancer benefit also now expected

Global four-in-one polypill trial to commence

Largest ever analysis on the use of a polypill in cardiovascular disease shows potential for improvements in patient care

Affiliation(s):

The George Institute country sites:

Copyright © 2019 The George Institute

Search form

Polypill - the power of one versus many

Kanyini Guidelines Adherence with the Polypill Study (Kanyini GAP)

Single Pill to Avert Cardiovascular Events (SPACE)

First international trial shows polypill halves predicted heart and stroke risk - cancer benefit also now expected

Global four-in-one polypill trial to commence

Largest ever analysis on the use of a polypill in cardiovascular disease shows potential for improvements in patient care